Quarantine Notice – Sodium Chloride ampoules

Posted November 27, 2023

The PHN is informing primary care providers that on 24/11/2023, the Public Health and Surveillance Branch in the Office of Health Protection of the Department of Health and Aged Care has issued a quarantine notice for the following product:

InterPharma Sodium Chloride 0.9% 10ml or 30ml ampoules.

The sponsor of the product will contact affected customers.

These products should be removed from use immediately and placed in quarantine until further notice.

The quarantine notice was released after several reported cases of Ralstonia pickettii in multiple jurisdictions, a pathogen with nosocomial significance.

For further questions, download the quarantine notice and contact details.

Explore more news like this:

More about:

HNECC PHN Announcement Pharmacy

For audiences:

General Practitioner Health Professionals Pharmacist

Keep up to date with the latest.

Subscribe to our mailing list to get all the latest news updates delivered to your inbox.

First Name

Last Name

Your Email Address

Which area from our region do you live/work?

Related News

January 10 2019

headspace funding for youth mental health

headspace will receive an additional $47 million to support the mental wellbeing of young Australians.

November 25 2019

PHN Commissioning Showcase

HNECC PHN had the privilege of co-hosting the 2019 Commissioning Showcase in Newcastle

February 25 2021

Culturally and Linguistically Diverse (CALD) Mental Health and COVID Grants

Five (5) grants of $6,000 each are available to CALD support organisations in the Hunter New England and Central Coast areas to develop video, audio and/or printed materials to encourage local people in CALD community groups impacted by the COVID-19 pandemic and associated social isolation to access local mental health and wellbeing support services.